Navigation Links
PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022
Date:1/15/2014

NEW YORK, Jan. 15, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022

http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022

Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit.

By the mid-to-late term of GlobalData's 2012 to 2022 forecast, Sanofi/Regeneron's dupilumab is expected to reshape the moderate and severe treatment landscape.

Other events that are expected to invoke change to the previously stagnant atopic dermatitis market include the launch of a non-steroidal topical from Anacor, AN2728, generic erosion of branded topicals Protopic and Elidel in the US, and the increasing use of pharmacological treatments in the growing markets of India and China.

Strong uptake of branded and generic topical calcineurin inhibitors as well as systemic vitamin derivatives will be the key growth drivers, while prescribing behavior of Indian dermatologists from GlobalData's July 2013 survey suggests a highly crowded, genericized market.

Scope

- Overview of Atopic Dermatitis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guideli
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmaPoint: Type 2 Diabetes - Brazil Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Alzheimers Disease - China Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
7. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
8. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
9. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
10. Signum Dermalogix Receives $1.6M Phase II SBIR Grant for the Development of Novel Atopic Dermatitis Therapeutics
11. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 Compassion & Choices today ... approved a bill that would authorize the option of medical ... 5-2. The ... , would allow mentally competent adults with six months or ... could take to painlessly and peacefully end an unbearable dying ...
(Date:5/28/2015)... 28, 2015  Shareholder rights law firm Robbins ... officers and directors of Eleven Biotherapeutics, Inc. (NASDAQGM: EBIO) ... is a clinical-stage biopharmaceutical company that engages in ... treat eye diseases, primarily in the ... this press release on the law firm,s Shareholder ...
(Date:5/28/2015)... Va. , May 28, 2015 National ... , RPh, MBA issued the following statement in response ... AARP Public Policy Institute documenting that a number of ... "This new report tracks with concerns previously expressed by ... to support patient access to essential medications. Moreover, a ...
Breaking Medicine Technology:California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 2California Committee Sends Medical Aid-in-Dying Bill to Senate Floor 3Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2NCPA: AARP Drug Pricing Report Reiterates Need for Fair Generic Drug Reimbursements 2
... - Results Presented at Endocrine Society,s 90th Annual ... June 16 ,Bionovo Inc. (Nasdaq: BNVI ) ... elements important in developing drugs for breast cancer ... Endocrine Society,s,90th Annual Meeting, showed that the new ...
... Metabolex, Inc., a,biopharmaceutical company focused on the ... treatment of metabolic diseases,announced today that it has ... MBX-8025 in overweight or obese patients with high ... designed to assess the drug,s,effect on dyslipidemia and ...
Cached Medicine Technology:Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs 2Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs 3Metabolex Completes Patient Enrollment in Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia 2
(Date:5/28/2015)... 2015 Dr. Jenyons’ Medical Weight ... deal to patients looking to undergo its advanced Micro-Needling ... patients will be able to get a single Micro-Needling ... $600. For a three-treatment package, which costs $1,800, the ... cost. , Dr. Juanita Jenyons, M.D., says Dr. Jenyons’ ...
(Date:5/28/2015)... Lanham, Md. (PRWEB) May 28, 2015 ... Weekend Sweepstakes grand prize winner Robert Davis of Newark, ... Davis to congratulate him on winning the $10,000 sweepstakes ... winners from over 100,000 entries from around the country ... prize. The drawing took place on May 21 at ...
(Date:5/28/2015)... Ross A. Clevens, MD, FACS, ... Teresa Beard as the new marketing director for Clevens ... oversee all marketing and promotional events for the practice. ... and developing compelling marketing strategies to achieve targeted results. ... served as guest communication manager at the Walt Disney ...
(Date:5/28/2015)... 28, 2015 As the summer approaches, many ... cool. It’s important to make safety a top priority, however, ... swimming tips. , According to the Centers for Disease Control, ... States, not including boating incidents. Additionally, the National Safety Council ... ages 1 to 4. , Amica is sharing the ...
(Date:5/28/2015)... 2015 ISMETT , a leading transplant ... the Sicilian economy by €132.5 million in expenditure in 2013, ... more than €73 million by retaining patients who otherwise would ... new study by the Battelle Memorial Institute. At the same ... and advanced health care management that is transforming Sicily into ...
Breaking Medicine News(10 mins):Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3Health News:AMVETS Announces Summer Sweepstakes Winners 2Health News:Clevens Face and Body Specialists Welcomes Teresa Beard as Marketing Director 2Health News:Splash! Amica Shares 6 Swimming Safety Tips 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3
... hearing loss in laboratory animals, according to two new ... of a pill that could stave off noise-induced and ... findings will be reported Wednesday at the Association for ... author Colleen Le Prell, Ph.D., a researcher at the ...
... National Head Start Association (NHSA) issued the following statement ... is the director of the Albina Head Start program ... be created -- and more than 200,000 existing jobs ... has signed into law the economic recovery package containing ...
... Quarterly EPS of $0.39, Total Revenues of $109.1 Million ... Total Revenues by 17% -- Company Generates $178.3 Million ... Gen-Probe Incorporated (Nasdaq: GPRO ... quarter and full year ended December 31, 2008, including ...
... MADISON, Wis., Feb. 17 /PRNewswire-FirstCall/ -- Cogdell ... appointment of Roger Herritz as President of the Midwest ... Inpatient Project Delivery for the Company,s wholly owned subsidiary, ... the Company,s Madison office, Mr. Herritz will be responsible ...
... Lingering physical effects of cancer a likely cause, finds study, ... fighting cancer wasn,t hard enough, a new Dutch study concludes ... be able to find a job. , The meta-analysis of ... those who,d battled cancer were out of work vs. 15.2 ...
... sent today to,President Obama and members of the ... leadership of Congress on the enactment of,the American ... the first time,provides financial incentives to physicians who ... improve both the quality and cost-,effectiveness of patient ...
Cached Medicine News:Health News:Vitamin supplements may protect against noise-induced hearing loss 2Health News:Vitamin supplements may protect against noise-induced hearing loss 3Health News:NHSA: President Obama, Congress Deserve High Praise for $2.1 Billion in Recovery Package for Head Start 2Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 2Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 3Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 4Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 5Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 6Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 7Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 8Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 9Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 10Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 11Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 12Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 13Health News:Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008 14Health News:Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman 2Health News:Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman 3Health News:Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman 4Health News:One in Three Cancer Survivors on Unemployment Line 2Health News:One in Three Cancer Survivors on Unemployment Line 3Health News:Allscripts Applauds Economic Stimulus Incentives Rewarding Physicians for Using Electronic Health Records 2Health News:Allscripts Applauds Economic Stimulus Incentives Rewarding Physicians for Using Electronic Health Records 3Health News:Allscripts Applauds Economic Stimulus Incentives Rewarding Physicians for Using Electronic Health Records 4Health News:Allscripts Applauds Economic Stimulus Incentives Rewarding Physicians for Using Electronic Health Records 5Health News:Allscripts Applauds Economic Stimulus Incentives Rewarding Physicians for Using Electronic Health Records 6
... The Vidiera NsP Nucleic Sample Preparation ... reaction setup. The platform can prepare ... tubes in just two and one half-hours, ... PCR reaction setup in 30 minutes each. ...
... The Invacare Platinum XL Concentrator offers all the ... Life to help lower lifecycle costs. Platinum XL ... before preventative maintenance is required by 40%! Platinum ... now a full 5 years with no hour ...
... new Platinum 10 concentrator. The Platinum 10 ... you have come to expect from the ... attractive alternative to liquid systems. The Platinum ... LPM for high flow patients, and has ...
... availability is November 2005. Specifications, including colors, ... than 5 lb (2.3 kg), FreeStyle by ... tailored specifically for those patients who know ... name suggests, FreeStyle captures the heart of ...
Medicine Products: